tiprankstipranks
Trending News
More News >
XRF Scientific Limited (AU:XRF)
:XRF
Australian Market
Advertisement

XRF Scientific Limited (XRF) AI Stock Analysis

Compare
33 Followers

Top Page

AU:XRF

XRF Scientific Limited

(Sydney:XRF)

Rating:77Outperform
Price Target:
AU$2.50
▲(30.21%Upside)
XRF Scientific Limited scores a 77, driven by strong financial performance and positive technical indicators, though tempered by a high valuation. The company's operational efficiency and market momentum are key strengths, but the high P/E ratio suggests potential overvaluation risks if growth is not sustained.

XRF Scientific Limited (XRF) vs. iShares MSCI Australia ETF (EWA)

XRF Scientific Limited Business Overview & Revenue Model

Company DescriptionXRF Scientific Limited (XRF) is an Australian-based company that specializes in the development, manufacturing, and distribution of equipment and chemicals used for sample preparation and analysis in the mining, industrial, and research sectors. The company is known for its high-performance products, including fusion equipment, flux, and platinum labware, which facilitate accurate and efficient material testing and quality control processes.
How the Company Makes MoneyXRF Scientific Limited generates revenue primarily through the sale of its proprietary equipment and consumables, which are used extensively in laboratory environments for sample preparation and analysis. The company offers a range of products including fusion machines, which are essential in preparing samples for X-ray fluorescence (XRF) analysis, a method widely used in the mining industry for determining the composition of materials. Additionally, XRF manufactures and sells platinum labware and certified reference materials that are critical for maintaining precision and standardization in analytical processes. The company's revenue streams are supported by its strong customer base in industries such as mining, construction materials, and research institutions. XRF also engages in partnerships and collaborations to enhance its market reach and technological capabilities, which further contribute to its financial performance.

XRF Scientific Limited Financial Statement Overview

Summary
XRF Scientific Limited exhibits a strong financial position with robust revenue and profit margins. The low debt levels and high equity ratio indicate financial stability, although attention is needed on cash flow trends to sustain liquidity.
Income Statement
87
Very Positive
XRF Scientific Limited has shown a strong revenue growth rate of 8.45% from 2023 to 2024, with significant gross profit and net profit margins at 43.88% and 14.85% respectively for 2024. The company also maintains a robust EBIT margin of 24.15% and an EBITDA margin of 25.61%, indicating solid operational efficiency. However, monitoring future revenue growth is crucial to maintain this trajectory.
Balance Sheet
80
Positive
The company exhibits financial stability with a low debt-to-equity ratio of 0.06, reflecting conservative leverage. A healthy return on equity (ROE) of 16.19% suggests effective use of shareholders' funds. An equity ratio of 80.43% underscores strong financial independence, minimizing risk of solvency issues. Nonetheless, maintaining such low leverage might limit growth potential.
Cash Flow
75
Positive
XRF Scientific Limited experienced a decrease in operating cash flow to net income ratio from 2023 to 2024, but maintains a positive free cash flow to net income ratio of 0.73, indicating sufficient cash generation. However, the free cash flow growth rate declined by 15.56%, warranting attention to reverse this trend for sustained liquidity and investment capacity.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue60.08M59.84M55.17M40.01M31.29M29.08M
Gross Profit27.43M26.27M22.00M16.46M12.89M11.34M
EBITDA15.97M15.32M13.22M9.44M8.05M5.86M
Net Income9.42M8.89M7.69M6.08M5.13M3.12M
Balance Sheet
Total Assets66.27M68.23M65.55M55.56M48.37M45.17M
Cash, Cash Equivalents and Short-Term Investments8.13M12.05M10.40M6.65M5.26M3.63M
Total Debt4.57M3.38M4.31M3.51M1.44M1.94M
Total Liabilities12.07M12.69M15.97M12.21M9.27M9.53M
Stockholders Equity54.21M54.89M49.25M43.48M39.10M35.64M
Cash Flow
Free Cash Flow9.37M6.45M7.63M2.63M3.86M3.45M
Operating Cash Flow10.37M8.09M8.42M3.15M4.51M4.20M
Investing Cash Flow-2.03M-1.64M-782.43K-1.11M-652.62K-753.41K
Financing Cash Flow-8.53M-4.80M-3.88M-648.95K-2.24M-3.05M

XRF Scientific Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.92
Price Trends
50DMA
1.79
Positive
100DMA
1.74
Positive
200DMA
1.77
Positive
Market Momentum
MACD
0.05
Positive
RSI
51.32
Neutral
STOCH
8.92
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRF, the sentiment is Neutral. The current price of 1.92 is below the 20-day moving average (MA) of 1.99, above the 50-day MA of 1.79, and above the 200-day MA of 1.77, indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 51.32 is Neutral, neither overbought nor oversold. The STOCH value of 8.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:XRF.

XRF Scientific Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
AU$272.64M28.6618.04%2.03%6.00%10.26%
62
Neutral
$10.37B10.131.50%2.95%2.32%-32.65%
46
Neutral
AU$100.90M-30.39%-41.05%-122.11%
36
Underperform
AU$381.37M-92.30%-100.00%65.31%
36
Underperform
AU$252.03M-12.08%46.56%
32
Underperform
AU$393.93M-38.25%20.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:XRF
XRF Scientific Limited
1.94
0.48
32.88%
AU:MTM
Mt Monger Resources Ltd.
0.72
0.69
2300.00%
AU:DTR
Dateline Resources Limited
0.12
0.11
1100.00%
AU:KAU
Kaiser Reef Ltd
0.16
0.00
0.00%
AU:GG8
Labyrinth Resources Limited
0.40
0.29
263.64%

XRF Scientific Limited Corporate Events

XRF Scientific Director Increases Shareholding
May 26, 2025

XRF Scientific Limited announced a change in the director’s interest, with Vance Stazzonelli acquiring 10,000 ordinary shares, increasing his total to 850,000 shares. This change, executed through a combination of off-market and on-market trades, reflects ongoing adjustments in the company’s leadership investments, potentially impacting stakeholder perceptions and the company’s market dynamics.

The most recent analyst rating on (AU:XRF) stock is a Buy with a A$2.22 price target. To see the full list of analyst forecasts on XRF Scientific Limited stock, see the AU:XRF Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 25, 2025